Tango Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
Tango Therapeutics (NASDAQ: TNGX) will report third quarter 2025 financial results on Tuesday, November 4, 2025 at 9:00 AM ET, to be released before the U.S. market open.
The company said it does not intend to hold a conference call with investors or analysts following the release.
Tango Therapeutics (NASDAQ: TNGX) pubblicherà i risultati finanziari del terzo trimestre 2025 il martedì 4 novembre 2025 alle 9:00 AM ET, da comunicare prima dell'apertura del mercato statunitense.
L'azienda ha dichiarato che non intende tenere una conferenza telefonica con investitori o analisti dopo la diffusione.
Tango Therapeutics (NASDAQ: TNGX) informará los resultados financieros del tercer trimestre de 2025 el martes 4 de noviembre de 2025 a las 9:00 AM ET, que se publicarán antes de la apertura del mercado de EE. UU.
La empresa indicó que no tiene la intención de realizar una conferencia telefónica con inversionistas o analistas tras el anuncio.
Tango Therapeutics (NASDAQ: TNGX)은 2025년 3분기 재무실적을 2025년 11월 4일 화요일 오전 9:00 ET에 발표하며, 미국 시장 개장 전에 공개됩니다.
회사는 발표 직후 투자자나 애널리스트와의 컨퍼런스 콜을 개최할 의향이 없다고 밝혔습니다.
Tango Therapeutics (NASDAQ: TNGX) publiera les résultats financiers du troisième trimestre 2025 le
La société a indiqué qu'elle n’envisage pas d’organiser une conférence téléphonique avec les investisseurs ou les analystes après la diffusion.
Tango Therapeutics (NASDAQ: TNGX) wird die Finanzergebnisse des dritten Quartals 2025 am Dienstag, dem 4. November 2025 um 9:00 Uhr ET vor dem US-Handelsstart bekannt geben.
Das Unternehmen teilte mit, dass es nicht beabsichtigt, nach der Bekanntgabe eine Telefonkonferenz mit Investoren oder Analysten abzuhalten.
Tango Therapeutics (NASDAQ: TNGX) ستصدر نتائج الربع الثالث من عام 2025 في الثلاثاء 4 نوفمبر 2025 في الساعة 9:00 صباحاً بتوقيت شرق الولايات المتحدة، قبل فتح السوق الأمريكية.
قالت الشركة إنها لا تعتزم عقد مؤتمر هاتفي مع المستثمرين أو المحللين عقب الإعلان.
Tango Therapeutics (NASDAQ: TNGX) 将于 2025年第三季度 财报在 2025年11月4日星期二 美国东部时间上午9点公布，内容在美国市场开盘前发布。
公司表示，它 无意在发布后与投资者或分析师进行电话会议。
- None.
- None.
BOSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that it will report third quarter 2025 financial results on November 4, 2025 at 9:00am ET, before the open of the U.S. financial markets. The company does not intend to hold a conference call.
About Tango Therapeutics
Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. For more information, please visit www.tangotx.com.
Investors and Media:
Elizabeth Hickin
IR@tangotx.com
media@tangotx.com
FAQ
When will Tango Therapeutics (TNGX) report Q3 2025 results?
Will Tango Therapeutics (TNGX) host a conference call for the November 4, 2025 release?
How can investors access Tango Therapeutics (TNGX) Q3 2025 results without a conference call?
What time will the Tango Therapeutics (TNGX) Q3 2025 results be released relative to market hours?
Will Tango Therapeutics (TNGX) provide supplemental materials with the November 4, 2025 release?
